Literature DB >> 16387843

Differential expression of adenosine receptors in human neutrophils: up-regulation by specific Th1 cytokines and lipopolysaccharide.

Andrée Fortin1, Danielle Harbour, Maria Fernandes, Pierre Borgeat, Sylvain Bourgoin.   

Abstract

Four types of adenosine receptors have been identified in different tissues and cell types, namely, A1, A2A, A2B, and A3 receptors. We report that A2AR but not A2BR mRNA in freshly isolated polymorphonuclear neutrophils (PMN) is maximally up-regulated after 4 h stimulation with lipopolysaccharide (LPS) or tumor necrosis factor alpha (TNF-alpha) and to a lesser extent, with interleukin (IL)-1beta. These effects were maintained up to 21 h. Consistent with changes in A2AR mRNA expression, up-regulation of A2AR protein was also detected after 4 h of LPS or TNF-alpha exposure. Up-regulation of A2AR protein expression was transient and returned to near basal levels after 12 h or 16 h stimulation with TNF-alpha or LPS, respectively. Conversely, IL-1beta failed to promote A2AR protein expression. Suppression of thapsigargin-induced leukotriene synthesis by the selective A2AR agonist CGS-21680 was found to be more pronounced when PMN were cultured for 4 h with LPS or TNF-alpha. In contrast, the up-regulation of A2AR has no impact on CGS-21680-induced inhibition of phospholipase D activation and superoxide production in response to formyl-Met-Leu-Phe. These results demonstrate that the A2AR is up-regulated by specific T helper cell type 1 cytokines and LPS. Although this could represent a potential feedback mechanism to control inflammation, the effect of A2AR up-regulation varied depending on the stimulus used to stimulate PMN functional responses after their incubation with proinflammatory mediators.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16387843     DOI: 10.1189/jlb.0505249

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  27 in total

1.  Involvement of purinergic signaling on nitric oxide production by neutrophils stimulated with Trichomonas vaginalis.

Authors:  Amanda Piccoli Frasson; Geraldo Attilio De Carli; Carla Denise Bonan; Tiana Tasca
Journal:  Purinergic Signal       Date:  2011-08-11       Impact factor: 3.765

2.  Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function.

Authors:  Balázs Csóka; Leonóra Himer; Zsolt Selmeczy; E Sylvester Vizi; Pál Pacher; Catherine Ledent; Edwin A Deitch; Zoltán Spolarics; Zoltán H Németh; György Haskó
Journal:  FASEB J       Date:  2008-07-14       Impact factor: 5.191

3.  Lack of adenosine A3 receptors causes defects in mouse peripheral blood parameters.

Authors:  Michal Hofer; Milan Pospíšil; Ladislav Dušek; Zuzana Hoferová; Denisa Komůrková
Journal:  Purinergic Signal       Date:  2014-04-25       Impact factor: 3.765

4.  Protective effect of adenosine receptors against lipopolysaccharide-induced acute lung injury.

Authors:  Joyce N Gonzales; Boris Gorshkov; Matthew N Varn; Marina A Zemskova; Evgeny A Zemskov; Supriya Sridhar; Rudolf Lucas; Alexander D Verin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-01-10       Impact factor: 5.464

5.  Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system.

Authors:  Pietro Enea Lazzerini; Mariarita Natale; Elena Gianchecchi; Pier Leopoldo Capecchi; Cinzia Montilli; Stefania Zimbone; Monica Castrichini; Epifania Balistreri; Gianluca Ricci; Enrico Selvi; Estrella Garcia-Gonzalez; Mauro Galeazzi; Franco Laghi-Pasini
Journal:  J Mol Med (Berl)       Date:  2011-10-28       Impact factor: 4.599

6.  Adenosine influences myeloid cells to inhibit aeroallergen sensitization.

Authors:  Hong Pei; Joel Linden
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-03-25       Impact factor: 5.464

7.  Finding better therapeutic targets for patients with asthma: adenosine receptors?

Authors:  R Polosa
Journal:  Br J Pharmacol       Date:  2008-10       Impact factor: 8.739

8.  Adenosine and stroke: maximizing the therapeutic potential of adenosine as a prophylactic and acute neuroprotectant.

Authors:  Rebecca L Williams-Karnesky; Mary P Stenzel-Poore
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

Review 9.  A2A receptors in inflammation and injury: lessons learned from transgenic animals.

Authors:  György Haskó; Pál Pacher
Journal:  J Leukoc Biol       Date:  2007-12-26       Impact factor: 4.962

10.  Activation of the A(3) adenosine receptor suppresses superoxide production and chemotaxis of mouse bone marrow neutrophils.

Authors:  Dharini van der Hoeven; Tina C Wan; John A Auchampach
Journal:  Mol Pharmacol       Date:  2008-06-26       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.